DS

Devi Shankar

Active Director Director DIN 09420939
DIN 09420939 First appointment Dec 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value •••• Premium profile

About Devi Shankar

Data last updated:

Devi Shankar is a Director at Skele Pharmaceuticals Private Limited (since 2021). The company operates in Chemicals. Skele Pharmaceuticals Private Limited reported revenue of ₹7.1 Lakh (FY 2023).

DIN 09420939
Primary Designation Director
Industry Chemicals
First Appointment 01 Dec 2021
Oldest Company Age 4 yrs
Largest company Skele Pharmaceuticals Private Limited · ₹7.1 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Dec 20212021₹7.1 Lakh (FY 2023)Active

Board colleagues of Devi Shankar

NameDINCompanyDesignation
Sudhir Pandey09420938Skele Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Skele Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Devi Shankar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Devi Shankar

Devi Shankar currently holds 1 directorship: Skele Pharmaceuticals Private Limited (Director, since 01 Dec 2021, revenue ₹7.1 Lakh (FY 2023)).

Devi Shankar was first appointed on 01 Dec 2021 as Director at Skele Pharmaceuticals Private Limited.

The current boards of Devi Shankar's companies include Sudhir Pandey (Skele Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available